Progress and perspectives in the development of a foot-and-mouth disease vaccine by recombinant DNA technology.
Brown
F
F
Department of Virology, Wellcome Biotechnology Ltd, Beckenham, Kent, UK.
D000818:Animals; D000956:Antigens, Viral / Q000138:chemical synthesis / Q000235:genetics / Q000276:immunology; D005537:Aphthovirus / Q000235:genetics / Q000276:immunology*; D002213:Capsid / Q000096:biosynthesis / Q000276:immunology; D036022:Capsid Proteins; D003001:Cloning, Molecular; D000939:Epitopes / Q000235:genetics / Q000276:immunology; D005536:Foot-and-Mouth Disease / Q000276:immunology / Q000517:prevention & control*; D005814:Genes, Viral; D010455:Peptides / Q000138:chemical synthesis / Q000276:immunology; D014612:Vaccines / Q000276:immunology*; D014614:Vaccines, Synthetic / Q000276:immunology*; D014765:Viral Vaccines / Q000276:immunology*
D000956:Antigens, Viral; D036022:Capsid Proteins; D000939:Epitopes; D010455:Peptides; D014612:Vaccines; D014614:Vaccines, Synthetic; D014765:Viral Vaccines